CACLP

26/01/2024

Policy | China's medical device industry has grown at a compound annual growth rate of 10.54% over the past five years and has become the second largest market in the world.

On 29 December 2023, the National Development and Reform Commission released a guidance encouraging the innovative development of high-end medical devices.

From 18 to 19 January, the 2024 National Medical Device Supervision and Administration Conference was held in Beijing. The meeting emphasized that China's medical device industry is currently in a critical period of rapid growth to high-quality development.

For further information, please view: https://en.caclp.com/industry-news/2663.html

25/01/2024

Event | CACLP & CISCE 2024 will be divided into 6 specialized zones. The Area concentrate on disposable or limited-use medical products for medical testing and laboratory testing.

Well-known exhibitors such as 3M, Randox, Gongdong Medical, Yangpu Medical, Tofflon, Corning, Tuoren Medical, Jet Bio-Filtration and Kangjian Medical will bring out their consumable products, catering to the diverse needs.

Register now for free 2-show pass at 🔗https://suburl.cn/G4inr1

25/01/2024

Passport holders from and will be exempt from visas for entry into each other's countries for purposes like tourism, family visits, business, and other private affairs, with a stay of no more than 30 days.

The agreement will officially come into effect on Feb. 9, 2024 (Chinese New Year's Eve).

For more information, please view: http://www.ecns.cn/news/cns-wire/2024-01-25/detail-ihcxacan3655017.shtml

(ECNS) -- Passport holders from China and Singapore will be exempt from visas for entry into each other's countries for purposes like tourism, family visits, business, and other private affairs, with a stay of no more than 30 days.

23/01/2024

Enlightening Lab Med - The 7th IVD Youth Entrepreneur Forum ( ) is scheduled to be held at Chongqing Yuelai International Conference Centre on 15 March in 2024.

The forum will invite executives from well-known listed in vitro diagnostic companies, industry experts, senior investment banking partners and other industry experts together to build a dialogue platform for young entrepreneurial groups, help young entrepreneurs to strengthen industrial innovation and enhance their comprehensive capabilities, in addition, to actively promote economic and social development to achieve new and greater progress.

For more information, please view: https://en.caclp.com/press-release/2659.html

23/01/2024

The 4th China Key Raw Material & Parts Forum ( ) is scheduled to be held at Chongqing Yuelai International Conventional Center on 15 March in 2024.

The forum will invite in vitro diagnostic industry association leaders, global in vitro diagnostic key raw materials and parts industry leaders, authoritative experts and senior investors in the biological industry to participate in exchanges, explore the industry's cutting-edge topics, and talk about the development plan of the industry.

For more information, please view: https://en.caclp.com/press-release/2656.html

19/01/2024

The 6th China IVD Distribution Enterprise Forum ( ) is scheduled to be held at Chongqing Yuelai International Conventional Center on 15 March 2024.

The forum will host esteemed experts, executives from listed companies, and leaders from third-party service organizations, fostering profound exchanges on the service ethos, quality control, and developmental experiences of IVD distribution enterprises. These discussions, approached from diverse perspectives, aim to drive discourse on quality and innovation within the IVD sector, charting a path towards the continued health and vibrancy of these enterprises within the distribution landscape.

For more information, please view: https://en.caclp.com/press-release/2653.html

19/01/2024

Event | CACLP & CISCE 2024 will be divided into 6 specialized zones. Focusing on the core part of medical device, the Area showcases a wide range of products crucial for scientific research and experimental analysis.

Notable exhibitors such as Intel, SMC, SAIS, Kamoer, ZEMIC, Burkert, ATS, Wendi Photoelectric, Foreach, NovelBeam, Keyto and IDEX will showcase their innovative components here and emphasize the pivotal role in improving the performance and stability of medical devices.

Register now for free 2-show pass at 🔗https://suburl.cn/G4inr1

18/01/2024

VIEW | With significant advances in optical physics and chemical engineering, state-of-the-art tissue-clearing methods can revolutionize the intact subcellular level of human tissue histological analysis, from thick human tissues to intact human organs.

The present review summarizes the principle of tissue clearing so that a trainee researcher can implement effective human tissue-clearing protocols.

Furthermore, this review highlights existing tissue-clearing methods in specific human tissue applications, describes imaging strategies, and presents various efficient computational approaches for processing and visualizing large image data. Finally, potential future directions for developing tissue-clearing methods for human tissues are also discussed.

For the full review, please see: https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20230046

17/01/2024

The 11th China IVD Industry Development Conference ( ) will be held grandly from March 16-17, 2024, at Chongqing Yuelai International Conference Center in China.

This year, the conference will focus on new trends and developments in the in vitro diagnostic industry. The conference will cover a wide range of topics, including IVD health economics, innovation, reform of medicine and healthcare system, centralized procurement, market status, international operational capabilities, investment and financing, strategic restructuring, enterprise incentive mechanisms, and cutting-edge technologies, providing comprehensive, multi-dimensional, and in-depth insights.

For more information, please view: https://en.caclp.com/press-release/2647.html

16/01/2024

Industry Analysis | In Vitro Diagnostic Industry in China: ——
The immunoassay method involves the widest range of items among all fields of medical detection; with the development of biomedical research, especially genomics and post-genomics results (high-resolution two-dimensional electrophoresis combined with mass spectrometry) which highly promote the research on disease-related markers, more and more items will be detected via immunoassay in the medical practice.

For more information, please view: https://en.caclp.com/industry-news/2644.html

16/01/2024

Business | 🤝 Virtue Diagnostic signed the global exclusive distribution rights contract with Revvity
💡 Illumina works with Sinocare to promote the localization of chip scanners and expand the local application of medical health genomics
🔬 MGI Tech and Xiji Biotechnology developed new cell storage products based on automated liquid nitrogen tank system
💊 Lyher’ s drug detection products obtained FDA (510k) registration certificate
📈 Chinese AI firm iFlyTek’s healthcare unit plans Hong Kong IPO

For more information, please view: https://en.caclp.com/industry-news/2641.html

12/01/2024

Event | CACLP & CISCE 2024 Event | CACLP & CISCE 2024 will be divided into 6 specialized zones. The Area will spotlight components such as antigens, antibodies, enzymes/coenzymes, NC membranes, luminescent substrates, microspheres/magnetic beads, primers, animal sera, proteins and more.

Roche, Thermo Fisher Scientific, Toyobo, Cytiva, Merck, Agilent, Fapon, Hzymes Biotech, Vazyme, NanoMicro, Medix Biochemica, Hytest and other global exhibitors will showcase high-quality raw material products.

Register now for free 2-show pass at 🔗https://suburl.cn/G4inr1

11/01/2024

The 9th China Experimental Medicine Conference (CEMC) will be held grandly from March 15-16, 2024 at Chongqing Yuelai International Conference Center.

Top global experts and scholars will engage in in-depth exchanges and discussions on topics such as advanced hospital management experience, experimental medicine management experience, innovative medical models, and how to further promote the process of hospital management and the implementation of the Healthy China strategy and the future hospitals management ideas in the field of experimental medicine.

For the full For more information, please view: https://en.caclp.com/press-release/2636.html

10/01/2024

Industry Analysis | The total number of first-time registrations of Class II and III medical devices in 2023 was 14,942, a decrease of 129 registrations compared with that of 2022.

Among them, 12,935 pieces of Class II products were registered for the first time, and 2007 pieces of Class III products were registered for the first time.

For more information, please view: https://en.caclp.com/industry-news/2633.html

09/01/2024

Industry Analysis | In Vitro Diagnostic Industry in China: ——
Chemiluminescence immunoassay reagent has become the mainstream product in the field of immunoassay and is widely used in clinical in vitro diagnosis due to its advantages such as high sensitivity, good specificity, a wide range of measurements, high degree of supporting automation, and excellent precision and accuracy.

The detection items presently carried out using chemiluminescence immunoassay mainly include: https://en.caclp.com/industry-news/2630.html

08/01/2024

Business | 💡 Roche introduces c-MET ADC of MediLink Therapeutics
🏥 Mindray partners with top hospitals to light the way for healthcare in Latin America
🌏 Tellgen Corporation set up a wholly-owned subsidiary, Tellgen Singapore Pte. Ltd
🚀 Fosun Diagnostics automatic chemiluminescence immunoanalyzer F-i1000 obtained EU IVDR certificate
🏆 VivaChek Link Plus 4G Glucose meter is approved by FDA 510(k)

For more information, please view: https://en.caclp.com/industry-news/2627.html

05/01/2024

Event | CACLP & CISCE 2024 will be divided into 6 specialized zones. The and Area, the heart of the CACLP show, will present an extensive array of instruments and reagents for testing, analysis and research in laboratory medicine.

These products cover the full range of products and latest technologies in haematology and humoral test, biochemistry test, immunology test, molecular and nucleic acid test, microbiology test, POCT, laboratory intelligent system, pathology test and blood transfusion test.

Global exhibitors including Danaher, Roche, Abbott, Zybio, Mindray, YHLO, Autobio, Wondfo, Snibe, Easy Diagnosis, Aikang, Dirui, Sansure, Daan Gene, BSBE, Hotgen and Joinstar will exhibit their latest products and the most advanced technology in this area.

Learn more about CACLP & CISCE exhibitors at 🔗 https://en.caclp.com/visit-exhibitor.html

04/01/2024

VIEW | (CRC) is a complex malignancy, influenced not only by cancer cells but also by the tumor microenvironment (TME).

Within the TME, emerging evidence highlights the presence and functional roles of diverse microbial entities, referred to as intratumoral microbiota. The distribution of these microbiota exhibits significant heterogeneity and engages in dynamic interactions with tumor cells, forming a unique ecosystem. Certain bacterial strains distinctly influence the TME of CRC, affecting the characteristics and progression of the tumor.

This review summarizes the intricate roles of intratumoral microbiota within CRC's TME, emphasizing their importance in the disease's development and progression, and discuss the opportunities and challenges in the field.

For the full research article, please view: https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20230100

03/01/2024

Industry Analysis | ​By the end of 2022, the number of companies with the production capacity of Class I medical devices in China reached 20,640, the number of Class II and Class III medical device manufacturers was 17,202, and the number of medical device operating companies exceeded 1.2 million, which is a rapid growth momentum.

For further information, please view: https://en.caclp.com/industry-news/2620.html

03/01/2024

Ready to elevate your expo experience? 🚀 Downloading on the App Store and Google Play to search everything you would like to know about the expo! Which feature of the CACLP Expo App are you most excited about? 📱✨

02/01/2024

Event | CACLP & CISCE 2024 Exhibitor Manual released! 📖✨ Download the manual here: https://en.caclp.com/exhibit-download.html

🚀 Whether you're a seasoned exhibitor or a first-timer, this comprehensive manual is designed to elevate your experience at the event.

💬 Have questions or need assistance? Our dedicated team is here to support you every step of the way: https://en.caclp.com/about-team.html

02/01/2024

Industry Analysis | In Vitro Diagnostic Industry in China: ——
There are 126 registered manufacturers of automatic chemiluminescence immuno-analyzers according to statistics of the National Medical Products Administration (NMPA) by December 2023, which may not be exhaustive since some manufacturers provides open chemiluminescence detection systems.

For more information, please view: https://en.caclp.com/industry-news/2617.html

29/12/2023

Event | CACLP & CISCE 2023 was thrilled to engage with diverse professionals shaping industries. Decision makers, advisors, evaluators and information collectors. 🌐Bringing IVD People Together! Shaping A Smarter Future Through Collaboration!

Registration for our 2024 event now available at 🔗 https://suburl.cn/G4inr1

28/12/2023

Industry Analysis | In 2023, China Chamber of Commerce of Medical & Health Products Importers & Exporters (CCCMHPIE) successively announced three batches of export brand certificates for companies recommended by CCCMHPIE in FY2023.

For further information, please view: https://en.caclp.com/industry-news/2614.html

28/12/2023

VIEW | Malfunction of neutrophil apoptosis and elevated serum lactate levels are the key cellular mechanism of immune suppressive status in septic patients.

However, whether increased lactate affects apoptosis of neutrophils and aggravates sepsis development, and the molecular mechanism remain unknown. In this study, first, we analyzed the transcriptional profiles of blood cells in sepsis patients (n = 39) and healthy volunteers (n = 40) to reveal that there is close correlation between the lactate-related gene expression changes associated with lactate production and immune function in leukocytes, especially in neutrophils.

Further, we explored the close relationship between lactate and delayed neutrophil apoptosis in human neutrophils. Programmed cell death 1 legand (PD-L1) was highly expressed in septic patients compared with healthy volunteers.

Then, we indicated that elevated levels of lactate in human neutrophils decreased neutrophil apoptosis (P < .001) by upregulating PD-L1 expression. Inhibition of monocarboxylate transporter 1 (MCT1) significantly attenuated neutrophil apoptosis caused by lactate (P < .001). We further performed in vivo experiments in sepsis mice model and determined that increased lactate decreased neutrophil apoptosis (P < .05) and reduces mice survival rate (P < .001), which could also be rescued by MCT1 inhibitor (P < .05).

This study revealed that elevated level of lactate in sepsis upregulates PD-L1 expression to decrease apoptosis through MCT1 in neutrophils, which provides new insight into sepsis treatment strategy by reducing lactate accumulation.

For the full research article, please view: https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20230053

27/12/2023

Industry Analysis | ​ , the next station for CACLP & CISCE in March 2024, is the most populated city and the fourth-largest economic hub in China.

From 2019 to 2023, the total number of medical device product registrations in Chongqing has reached 2,473. In 2023, this number is 1,139 with a growth rate of up to 89.4% in 2022.

For further information, please view: https://en.caclp.com/industry-news/2611.html

26/12/2023

Business | 🌏 Roche continues to realize localization through innovation and cooperation in China
🏛️ Agilent and China Pharmaceutical University built a demonstration laboratory for biomedical analysis technology
👥 Officials from the Cambodian Ministry of Health visited Sansure Biotech
🤝 Micropoint Biotechnologies signed a localization cooperation agreement with Indonesian partners
🚀 Lansion Biotechnology & Dheyma Global Ventures, Bhutan officially launched global strategic cooperation

For more information, please view: https://en.caclp.com/industry-news/2610.html

26/12/2023

The 2024 CACLP & CISCE is now available for exploration on our new . Download on the App Store and Google Play. 📲 Search, discover, and add your favorites to saved for a seamless event experience! 🌐🔍

25/12/2023

Industry Analysis | In Vitro Diagnostic Industry in China: ——
By rapid development of China's immunoassay, the market share of chemiluminescence has gradually expanded. Immunoassay diagnosis was already the largest sub-field of the market in China, currently accounting for about 25%.

For more information, please view: https://en.caclp.com/industry-news/2609.html

25/12/2023

🚀 Experience the CACLP expo like never before with our official all-in-on !

Seamlessly navigate the exhibitors/products, stay informed on schedule updates, and personalize your trip effortlessly.

Available now on the App Store and Google Play. 📲✨